Verve Therapeutics (VERV) Stock Chart & Stock Price History $11.13 0.00 (0.00%) As of 07/25/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verve Therapeutics Stock Price Performance The Verve Therapeutics (VERV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 76.39%, with a year-to-date return of 97.34%. In the past month, the stock has decreased 0.71%, reflecting recent market activity. As of the latest close, Verve Therapeutics traded at $11.13 with a market cap of $992.13 million and volume of 0 shares. Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance-0.71%3 Month Performance+114.45%Year-To-Date Performance+97.34%1 Year Performance+76.39% VERV Stock Chart for Saturday, August, 2, 2025 VERV Chart by TradingView Verve Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$11.13$11.21+0.67%$11.25$11.1010.31 million shs$998.81 million07/24/2025$11.10$11.13+0.27%$11.25$11.1010.30 million shs$992.13 million07/23/2025$11.08$11.10+0.18%$11.14$11.0819.93 million shs$989.49 million07/22/2025$10.93$11.08+1.37%$11.09$10.913.96 million shs$987.67 million07/21/2025$10.91$10.93+0.18%$11.08$10.932.24 million shs$974.30 million07/18/2025$10.95$10.91-0.37%$10.99$10.904.91 million shs$972.52 million07/17/2025$11.02$10.95-0.64%$11.05$10.935.61 million shs$976.12 million07/16/2025$11.02$11.02$11.08$11.002.19 million shs$982.32 million07/15/2025$11.03$11.02-0.09%$11.06$11.003.53 million shs$982.36 million07/14/2025$11.03$11.03$11.09$11.011.95 million shs$983.25 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$11.06$11.03-0.27%$11.09$11.022.42 million shs$983.25 million07/10/2025$11.09$11.06-0.27%$11.14$11.042.37 million shs$985.89 million07/09/2025$11.13$11.09-0.36%$11.20$11.092.64 million shs$988.56 million07/08/2025$11.16$11.13-0.27%$11.29$11.132.47 million shs$992.16 million07/07/2025$11.23$11.16-0.58%$11.30$11.162.49 million shs$994.80 million07/04/2025$11.23$11.23$11.29$11.221.14 million shs$1.00 billion07/03/2025$11.21$11.23+0.13%$11.29$11.221.14 million shs$1.00 billion07/02/2025$11.28$11.21-0.62%$11.34$11.213.18 million shs$999.26 million07/01/2025$11.23$11.28+0.45%$11.33$11.164.13 million shs$1.01 billion Related Companies Beam Therapeutics Stock Chart Zai Lab Stock Chart Arcellx Stock Chart PTC Therapeutics Stock Chart ACADIA Pharmaceuticals Stock Chart Viking Therapeutics Stock Chart SpringWorks Therapeutics Stock Chart Ascentage Pharma Group International Stock Chart MoonLake Immunotherapeutics Stock Chart Protagonist Therapeutics Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERV Stock Alerts